Combination Therapy with Ciprofloxacin and Pentamidine against Multidrug-Resistant
Galleria mellonella
MexAB-OprM
antibiotic resistance
antibiotic resistance breaker
drug repurposing
efflux pump inhibitor
synergy
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
26 Jul 2023
26 Jul 2023
Historique:
received:
11
07
2023
revised:
24
07
2023
accepted:
25
07
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
The aim of this work was to (i) evaluate the efficacy of a combination treatment of pentamidine with ciprofloxacin against
Identifiants
pubmed: 37627656
pii: antibiotics12081236
doi: 10.3390/antibiotics12081236
pmc: PMC10451767
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : University of St Andrews
ID : N/A
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Antimicrob Agents Chemother. 1999 Jun;43(6):1340-6
pubmed: 10348749
Nat Chem Biol. 2011 Jun;7(6):348-50
pubmed: 21516114
Front Cell Infect Microbiol. 2021 Apr 16;11:665759
pubmed: 33937104
Biochim Biophys Acta. 1973 May 25;307(3):491-512
pubmed: 4581497
Drugs Context. 2018 May 29;7:212527
pubmed: 29872449
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1288-1301
pubmed: 27573805
Front Microbiol. 2015 Apr 28;6:377
pubmed: 25972857
Int J Antimicrob Agents. 2014 Mar;43(3):254-61
pubmed: 24361354
J Antimicrob Chemother. 2015 Aug;70(8):2271-8
pubmed: 25921513
J Appl Microbiol. 2000 Feb;88(2):213-9
pubmed: 10735988
Radiat Res. 2007 Feb;167(2):167-75
pubmed: 17390724
BMC Complement Altern Med. 2017 Aug 14;17(1):405
pubmed: 28806947
J Med Microbiol. 1995 Oct;43(4):300-9
pubmed: 7562993
Front Cell Infect Microbiol. 2018 Oct 18;8:363
pubmed: 30406040
PLoS One. 2013;8(3):e60666
pubmed: 23544160
Antibiotics (Basel). 2020 Dec 09;9(12):
pubmed: 33317111
Front Microbiol. 2011 Apr 05;2:65
pubmed: 21747788
Pharmacotherapy. 2011 Jun;31(6):598-608
pubmed: 21923444
Rev Infect Dis. 1985 Sep-Oct;7(5):625-34
pubmed: 3903942
Nat Microbiol. 2017 Mar 06;2:17028
pubmed: 28263303
Curr Opin Pharmacol. 2019 Oct;48:92-98
pubmed: 31454708
BMJ. 1998 Dec 5;317(7172):1572
pubmed: 9836663
Antimicrob Agents Chemother. 1995 Mar;39(3):790-2
pubmed: 7793896
FEMS Microbiol Lett. 2001 Aug 7;202(1):139-43
pubmed: 11506922
Antimicrob Agents Chemother. 1995 Sep;39(9):1948-53
pubmed: 8540696
BMJ. 2004 May 1;328(7447):1073
pubmed: 15117797
J Antimicrob Chemother. 2008 Dec;62(6):1265-8
pubmed: 18819973
J Med Microbiol. 2019 Jan;68(1):1-10
pubmed: 30605076
ACS Infect Dis. 2022 Apr 8;8(4):768-777
pubmed: 35319198
Expert Rev Respir Med. 2016 Jun;10(6):685-97
pubmed: 27175979
Interdiscip Perspect Infect Dis. 2012;2012:765205
pubmed: 22919379
Antimicrob Agents Chemother. 1994 Jul;38(7):1466-9
pubmed: 7979273
Acta Biochim Biophys Sin (Shanghai). 2007 Nov;39(11):901-13
pubmed: 17989882
J Med Microbiol. 2014 Jul;63(Pt 7):945-955
pubmed: 24928215
J Antimicrob Chemother. 2021 Jul 15;76(8):2172-2181
pubmed: 33993273
Clin Microbiol Rev. 2009 Oct;22(4):582-610
pubmed: 19822890